Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Novartis buys Genoptix

You may also be interested in...



New Products In Brief

Sonitus’ SoundBite gains second FDA OK

New Products In Brief

Sonitus’ SoundBite gains second FDA OK

HeartWare Points To Less Acute Patients As One Key To HVAD Success

As HeartWare awaits an approval decision for its first left ventricular assist device, the company says it is continuing to advance its pipeline and push forward with a longer-term strategy to maximize the treatable population for the product.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029804

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel